Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis.
J Cyst Fibros
; 21(5): 792-799, 2022 09.
Article
in En
| MEDLINE
| ID: mdl-35300931
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sinusitis
/
Cystic Fibrosis
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Child
/
Humans
/
Middle aged
Language:
En
Journal:
J Cyst Fibros
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
Netherlands